Walder Wyss has advised SixPeaks Bio AG and its shareholders (including Versant Ventures). Lenz & Staehelin has advised AstraZeneca. AstraZeneca has completed the acquisition of Swiss...
AstraZeneca Acquires Swiss Biotech Firm SixPeaks Bio in USD 300 Million Deal
Consortium Launches Sferical AI AB for Advanced AI Infrastructure in Sweden
Gernandt & Danielsson has advised a consortium consisting of AstraZeneca, Ericsson, Saab, SEB and Wallenberg Investments. A consortium comprised of AstraZeneca, Ericsson, Saab, SEB and Wallenberg...
AstraZeneca’s $1 Billion Acquisition of EsoBiotec
Covington & Burling advised AstraZeneca on the deal. AstraZeneca (LSE/STO/Nasdaq: AZN) announced its definitive agreement to acquire EsoBiotec SA, a biotechnology company pioneering in vivo cell...
AstraZeneca’s $545m Deal with Pinetree for EGFR Degrader
Gowling WLG advised AstraZeneca on exclusive option and global license agreement with Pinetree Therapeutics. AstraZeneca has entered into an exclusive option and global license agreement with...
SixPeaks Bio AG’s $110 Million Series A Financing Round
Walder Wyss advised SixPeaks Bio AG while Lenz & Staehelin acted as Swiss counsel to AstraZeneca. SixPeaks Bio AG has secured USD30 million in Series A...
AstraZeneca’s Collaboration with Quell Therapeutics
Gowling WLG advised AstraZeneca on the agreement. Cooley LLP advised Quell Therapeutics. A collaboration and license agreement has been established between AstraZeneca and biopharmaceutical company Quell...
AstraZeneca’s Acquisition of CinCor Pharma
Covington & Burling advised AstraZeneca. Skadden represented Centerview Partners LLC, the exclusive financial advisor to CinCor Pharma Inc. Cooley advised CinCor Pharma. CinCor Pharma Inc. (“CinCor”)...
AstraZeneca’s Agreement with Scorpion Therapeutics
Gowling WLG advised AstraZeneca on the transaction. AstraZeneca started a collaboration with Scorpion Therapeutics, Inc. (“Scorpion”) to develop precision medicines against previously hard-to-target cancer proteins. Scorpion will...
AstraZeneca v. Mylan Pharmaceuticals Inc.
Williams & Connolly LLP advised AstraZeneca on the deal. AstraZeneca obtained a trial victory in a high-stakes Hatch-Waxman patent litigation against Mylan Pharmaceuticals Inc. involving three patents covering...
AstraZeneca’s Strategic Collaboration With Junshi Biosciences
Sidley Austin LLP advised AstraZeneca China on the deal. AstraZeneca China announced a strategic collaboration with Shanghai Junshi Biosciences Co., Ltd. (Junshi Biosciences). AstraZeneca China will be...